Clinical Social Workers in East Yaphank, NY Accepting Medicare
7 Clinical Social Workers found. Showing 1 - 7
 Ms. Sharnisha Lichele Wheeler, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 141 Colin Drive, Suite 1, East Yaphank, NY 11967 Phone: 631-205-5820 Fax: 631-205-5826 |
Mrs. Alison Lamonica, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1490 William Floyd Pkwy, East Yaphank, NY 11967 Phone: 631-924-3741 Fax: 631-924-2413 |
Ms. Tara Justine Mchugh, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 141 Colin Drive, East Yaphank, NY 11967 Phone: 631-205-2820 Fax: 631-205-5826 |
Mrs. Evelyn G Edwards, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1490 William Floyd Parkway, East Yaphank, NY 11967 Phone: 631-924-3741 |
 Mr. Tomas Gonzalez, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1490 William Floyd Pkwy., Family Service League, East Yaphank, NY 11967 Phone: 631-924-3741 |
Mrs. Elizabeth P Degrocco, LCSW-R Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1490 William Floyd Pkwy, East Yaphank, NY 11967 Phone: 631-924-3741 Fax: 631-924-2413 |
Mrs. Doreen Lorraine Fratello, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1490 William Floyd Parkway, Suite 108, East Yaphank, NY 11967 Phone: 631-924-3741 Fax: 631-924-2413 |
News Archive
Antibodies neutralize mosquito-transmitted chikungunya virus, researchers reveal
Researchers have learned the precise structure of the mosquito-transmitted chikungunya virus pathogen while it is bound to antibodies, showing how the infection is likely neutralized.
Study links low socioeconomic status to ill health and early death
Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a study of 1.7 million people published by The Lancet.
The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD
Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.
First Edition: August 16, 2010
Today's headlines reflect coverage of state health reform implementation issues as well as other emerging policy issues in the nation's health system.
Political cartoon: 'Second Opinion?'
Kaiser Health News provides a fresh perspective on health policy developments with "Second Opinion?" by Gary Varvel.
› Verified 3 days ago